BioArctic AB (publ) (BIOA-B) — Capital Reinvestment Ratio

Latest as of December 2025: 1.00x

BioArctic AB (publ) (BIOA-B) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr313.33 Million) in capital expenditures (Skr313.33 Million). Check BioArctic AB (publ) tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.00x
Capex / Operating Cash Flow

Operating Cash Flow

Skr313.33 Million
SEK

Capital Expenditures

Skr313.33 Million
SEK

Data as of

Dec 2025
Most recent filing

BioArctic AB (publ) Capital Reinvestment Ratio (2016–2025)

This chart tracks BioArctic AB (publ)'s Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see BioArctic AB (publ) cash conversion from operations.

Annual Capital Reinvestment Ratio for BioArctic AB (publ) (2016–2025)

Year-by-year Capital Reinvestment Ratio for BioArctic AB (publ) from 2016 to 2025. See BioArctic AB (publ) (BIOA-B) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2025 0.01x Skr1.43 Billion Skr10.24 Million ▼ -70.2%
2023 0.02x Skr309.69 Million Skr7.44 Million ▲ +141.0%
2019 0.01x Skr327.17 Million Skr3.26 Million ▲ +126.9%
2016 0.00x Skr675.13 Million Skr2.97 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow